Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain-Reference-Cited by-同舟云学术

Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain

Published:2016-08-10 Issue:16 Volume:59 Page:7525-7543
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Seltzman Herbert H.¹,Shiner Craig¹,Hirt Erin E.¹,Gilliam Anne F.¹,Thomas Brian F.¹,Maitra Rangan¹,Snyder Rod¹,Black Sherry L.¹,Patel Purvi R.¹,Mulpuri Yatendra²,Spigelman Igor²

Affiliation:

1. Center for Drug Discovery, Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States

2. Division of Oral Biology & Medicine, School of Dentistry, University of California, 10833 Le Conte Avenue, 63-078 CHS, Los Angeles, California 090095-1668, United States

Funder

University of California, Los Angeles

National Institute on Drug Abuse

Academic Senate, University of California, Los Angeles

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00516

Reference85 articles.

1. The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey